BioLife Solutions to Buy SciSafe in $30 Million Deal

BioLife Solutions to Buy SciSafe in $30 Million Deal

The price is $30 million, which will be paid half in cash and half in newly issued BioLife common shares. The incentive plan will be in force for a period of four years, but BioLife did not provide any further details about the milestones to be hit. At BioLife's current share price, 626,000 shares would be worth just under $17 million.